Michael J. Wiley
Net Worth
Last updated:
What is Michael J. Wiley net worth?
The estimated net worth of Mr. Michael J. Wiley is at least $33,596,534 as of 29 Apr 2020. He owns shares worth $6,506,839 as insider, has earned $23,247,415 from insider trading and has received compensation worth at least $3,842,280 in Guardant Health, Inc..
What is the salary of Michael J. Wiley?
Mr. Michael J. Wiley salary is $640,380 per year as Head of Corporation Affairs in Guardant Health, Inc..
How old is Michael J. Wiley?
Mr. Michael J. Wiley is 49 years old, born in 1976.
What stocks does Michael J. Wiley currently own?
As insider, Mr. Michael J. Wiley owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Guardant Health, Inc. (GH) | Head of Corporation Affairs | 111,171 | $58.53 | $6,506,839 |
What does Guardant Health, Inc. do?
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.
Michael J. Wiley insider trading
Guardant Health, Inc.
Mr. Michael J. Wiley has made 13 insider trades between 2019-2020, according to the Form 4 filled with the SEC. Most recently he sold 3,780 units of GH stock worth $302,801 on 29 Apr 2020.
The largest trade he's ever made was exercising 90,000 units of GH stock on 18 Apr 2019. As of 29 Apr 2020 he still owns at least 111,171 units of GH stock.
Guardant Health key executives
Guardant Health, Inc. executives and other stock owners filed with the SEC:
- Dr. AmirAli Talasaz Ph.D. (46) Co-Chief Executive Officer & Director
- Dr. Helmy Eltoukhy Ph.D. (46) Co-Founder, Co-Chief Executive Officer & Chairman
- Mr. John G. Saia (52) Senior Vice President, Gen. Counsel & Corporation Sec.
- Mr. Michael J. Wiley (49) Head of Corporation Affairs